NOTCH1 and neoplasm: Moreover, Mittal and colleagues, by using a novel monoclonal antibody to inhibit Notch1 (MAb602.101), observed a significant reduction in tumor growth and in the number and sizes of mammospheres compared to controls, thus resulting in the depletion of the putative cancer stem-like cell subpopulation [66].